141 related articles for article (PubMed ID: 10917578)
1. An open-label, randomized multicenter study comparing the efficacy and safety of Cyclo 3 Fort versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency.
Beltramino R; Penenory A; Buceta AM
Angiology; 2000 Jul; 51(7):535-44. PubMed ID: 10917578
[TBL] [Abstract][Full Text] [Related]
2. An open-label, randomised multicentre study comparing the efficacy and safety of CYCLO 3 FORT versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency.
Beltramino R; Penenory A; Buceta AM
Int Angiol; 1999 Dec; 18(4):337-42. PubMed ID: 10811525
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency.
Boyle P; Diehm C; Robertson C
Int Angiol; 2003 Sep; 22(3):250-62. PubMed ID: 14612852
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of a single daily dose of two capsules Cyclo 3 Fort in the morning versus a repeated dose of one capsule morning and noon. A one-month study.
Boccalon H; Causse C; Yubero L
Int Angiol; 1998 Sep; 17(3):155-60. PubMed ID: 9821028
[TBL] [Abstract][Full Text] [Related]
5. [Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs].
Pedersen FM; Hamberg O; Sørensen MD; Neland K
Ugeskr Laeger; 1992 Sep; 154(38):2561-3. PubMed ID: 1413183
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a Butcher's broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency.
Vanscheidt W; Jost V; Wolna P; Lücker PW; Müller A; Theurer C; Patz B; Grützner KI
Arzneimittelforschung; 2002; 52(4):243-50. PubMed ID: 12040966
[TBL] [Abstract][Full Text] [Related]
7. Correlation between improvement in functional signs and plethysmographic parameters during venoactive treatment (Cyclo 3 Fort).
Allaert FA; Hugue C; Cazaubon M; Renaudin JM; Clavel T; Escourrou P
Int Angiol; 2011 Jun; 30(3):272-7. PubMed ID: 21617611
[TBL] [Abstract][Full Text] [Related]
8. Clinical and capillaroscopic evaluation in the treatment of chronic venous insufficiency with Ruscus aculeatus, hesperidin methylchalcone and ascorbic acid in venous insufficiency treatment of ambulatory patients.
Aguilar Peralta GR; Arévalo Gardoqui J; Llamas Macías FJ; Navarro Ceja VH; Mendoza Cisneros SA; Martínez Macías CG
Int Angiol; 2007 Dec; 26(4):378-84. PubMed ID: 18091707
[TBL] [Abstract][Full Text] [Related]
9. New data on chronic venous disease: a new place for Cyclo 3® Fort.
Kakkos SK; Bouskela E; Jawien A; Nicolaides AN
Int Angiol; 2018 Feb; 37(1):85-92. PubMed ID: 29063748
[TBL] [Abstract][Full Text] [Related]
10. [Cyclo 3 fort--alternative in chronic venous insufficiency].
Stoianova V
Akush Ginekol (Sofiia); 2006; 45 Suppl 3():78-80. PubMed ID: 18240734
[No Abstract] [Full Text] [Related]
11. A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency.
Bergqvist D; Hallböök T; Lindblad B; Lindhagen A
Vasa; 1981; 10(3):253-60. PubMed ID: 7025500
[No Abstract] [Full Text] [Related]
12. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study.
Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Di Renzo A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M
Angiology; 2005; 56(1):1-8. PubMed ID: 15678250
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
Cappelli R; Pecchi S; Oberhauser V; Forconi S; Di Perri T
Int J Clin Pharmacol Res; 1987; 7(4):291-9. PubMed ID: 3596872
[TBL] [Abstract][Full Text] [Related]
14. Comparison between the efficacy and tolerability of oxerutins and troxerutin in the treatment of patients with chronic venous insufficiency.
Rehn D; Golden G; Nocker W; Diebschlag W; Lehmacher W
Arzneimittelforschung; 1993 Oct; 43(10):1060-3. PubMed ID: 8267669
[TBL] [Abstract][Full Text] [Related]
15. Treatment of secondary lymphedema of the upper limb with CYCLO 3 FORT.
Cluzan RV; Alliot F; Ghabboun S; Pascot M
Lymphology; 1996 Mar; 29(1):29-35. PubMed ID: 8721977
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness and safety of hydroxyethyl-rutosides in the local treatment of symptoms of venous insufficiency during air travel].
Gouny AM; Horovitz D; Gouny P; Sauvage E; Nussaume O
J Mal Vasc; 1999 Jun; 24(3):214-20. PubMed ID: 10467532
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological targets of drugs employed in chronic venous and lymphatic insufficiency.
Boisseau MR
Int Angiol; 2002 Jun; 21(2 Suppl 1):33-9. PubMed ID: 12515978
[TBL] [Abstract][Full Text] [Related]
18. Oxerutins (Venoruton): efficacy in chronic venous insufficiency--a double-blind, randomized, controlled study.
Petruzzellis V; Troccoli T; Candiani C; Guarisco R; Lospalluti M; Belcaro G; Dugall M
Angiology; 2002; 53(3):257-63. PubMed ID: 12025912
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of hydroxyethylrutosides in the treatment of chronic venous insufficiency.
Poynard T; Valterio C
Vasa; 1994; 23(3):244-50. PubMed ID: 7975870
[TBL] [Abstract][Full Text] [Related]
20. Quality of life improvement in Latin American patients suffering from chronic venous disorder using a combination of Ruscus aculeatus and hesperidin methyl-chalcone and ascorbic acid (quality study).
Guex JJ; Avril L; Enrici E; Enriquez E; Lis C; Taïeb C
Int Angiol; 2010 Dec; 29(6):525-32. PubMed ID: 21173734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
